Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

Lorie A Ellis,1 Elisabetta Malangone-Monaco,2 Helen Varker,3 Diana Stetsovsky,3 Maureen Kubacki,1 Raphael J DeHoratius,1,4 Shelly Kafka1 1Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA; 2Life Sciences, IBM Watson Health, Armonk, NY, USA; 3Life Sciences, IBM Watson H...

Full description

Bibliographic Details
Main Authors: Ellis LA, Malangone-Monaco E, Varker H, Stetsovsky D, Kubacki M, DeHoratius RJ, Kafka S
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Rheumatoid arthritis
infliximab
golimumab
dosing
treatment patterns
Online Access:https://www.dovepress.com/comparative-analysis-of-us-real-world-dosing-patterns-and-direct-infus-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/comparative-analysis-of-us-real-world-dosing-patterns-and-direct-infus-peer-reviewed-article-CEOR

Similar Items